IRIS
PORZIO, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.639
AS - Asia 2.671
EU - Europa 2.239
SA - Sud America 472
AF - Africa 63
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.096
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.571
SG - Singapore 1.179
IE - Irlanda 700
CN - Cina 606
BR - Brasile 407
TR - Turchia 364
DE - Germania 323
HK - Hong Kong 295
RU - Federazione Russa 257
UA - Ucraina 189
GB - Regno Unito 158
IT - Italia 158
SE - Svezia 147
FI - Finlandia 104
VN - Vietnam 85
FR - Francia 52
CZ - Repubblica Ceca 43
CA - Canada 38
PL - Polonia 33
IN - India 29
BE - Belgio 23
MA - Marocco 21
ZA - Sudafrica 21
JP - Giappone 19
MX - Messico 19
BD - Bangladesh 15
AR - Argentina 13
IQ - Iraq 13
EC - Ecuador 10
PY - Paraguay 10
ES - Italia 9
NL - Olanda 9
UZ - Uzbekistan 9
CO - Colombia 8
TN - Tunisia 8
JO - Giordania 7
PE - Perù 7
PK - Pakistan 7
ID - Indonesia 6
IL - Israele 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
KE - Kenya 5
AT - Austria 4
AZ - Azerbaigian 4
BO - Bolivia 4
CL - Cile 4
EU - Europa 4
JM - Giamaica 4
LT - Lituania 4
RS - Serbia 4
DZ - Algeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
AL - Albania 2
BG - Bulgaria 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
PH - Filippine 2
SA - Arabia Saudita 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GY - Guiana 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LY - Libia 1
MC - Monaco 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 10.096
Salva come PNG Salva come JPEG
Città #
Chandler 712
Jacksonville 705
Dublin 700
Singapore 576
Dallas 535
Hong Kong 294
Boardman 224
Santa Clara 222
Ashburn 219
Izmir 156
Ann Arbor 141
Wilmington 113
Nanjing 112
New York 110
Lawrence 102
Princeton 102
Beijing 89
The Dalles 78
San Mateo 72
Los Angeles 60
Munich 60
Columbus 50
Moscow 50
Bremen 49
Dearborn 43
Brno 42
São Paulo 41
Shenyang 40
Seattle 38
Nanchang 37
Helsinki 35
Warsaw 30
Milan 29
Ho Chi Minh City 27
Woodbridge 27
Jinan 26
L'aquila 25
Brussels 23
Montreal 22
Tianjin 22
Des Moines 21
Hebei 20
Mountain View 20
Düsseldorf 19
Tokyo 19
Kunming 18
London 18
Stockholm 18
Casablanca 17
Assago 16
Atlanta 16
Dong Ket 16
Johannesburg 16
San Francisco 16
Hefei 15
Verona 15
Denver 14
Norwalk 14
Brooklyn 13
Falkenstein 13
Ningbo 13
Zhengzhou 13
Guangzhou 12
Jiaxing 12
Changsha 11
Hanoi 11
Council Bluffs 10
Frankfurt am Main 10
Philadelphia 10
Phoenix 10
Belo Horizonte 9
Chicago 9
Rio de Janeiro 9
Shanghai 9
Chennai 8
Fortaleza 8
Mexico City 8
Monza 8
Orem 8
Poplar 8
Querétaro 8
Rome 8
Tappahannock 8
Tashkent 8
Boston 7
Brasília 7
Curitiba 7
Haiphong 7
Pune 7
Amman 6
Amsterdam 6
Hangzhou 6
Oklahoma City 6
San Jose 6
Taizhou 6
Toronto 6
Turku 6
Berlin 5
Fremont 5
Lanzhou 5
Totale 6.698
Salva come PNG Salva come JPEG
Nome #
The supportive care task force at the University of L'Aquila: 2-years experience 178
Does pain intensity predict a poor opioid response in cancer patients? 153
Epidemiology and Characteristics of Episodic Breathlessness In Advanced Cancer Patients: An Observational Study 153
Tapentadol in cancer pain management: a prospective open-label study 136
Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study 132
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 126
Age differences in the last week of life in advanced cancer patients followed at home 123
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 123
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 122
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 120
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 120
Pain evaluation and management: a survey of Italian radiotherapists 118
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 116
Multimodality treatment in metastatic gastric cancer: From past to next future 116
Efficacy of pregabalin in the management of cetuximab-related itch 115
Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit 115
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 114
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience 112
Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients 112
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 111
Assessment and treatment of symptoms among italian medical oncologists 110
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 110
Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy 110
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 110
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 110
The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program 108
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 108
Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine 108
Pattern of symptoms and symptomatic treatment in adults and the aged population: A retrospective analysis of advanced cancer patients followed at home 107
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 107
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 107
Pain intensity as prognostic factor in cancer pain management 106
What Is Known about Theragnostic Strategies in Colorectal Cancer 106
Palliative sedation in patients with advanced cancer followed at home: A systematic review 105
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 105
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 105
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 103
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 103
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 102
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab 102
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings 102
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 102
Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study 102
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids 101
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 101
Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings. 100
Dosing fentanyl buccal tablet for breakthrough cancer pain: Dose titration versus proportional doses 100
Can malignant bowel obstruction in advanced cancer patients be treated at home ? 99
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting 99
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 99
Breakthrough pain in oncology: A longitudinal study 99
Palliative radiotherapy in advanced cancer patients treated with immune‑checkpoint inhibitors: The PRACTICE study 99
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 98
Physical Exercise and Quality of Life in Breast Cancer Survivors 97
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 97
Palliative care in advanced cancer patients: how and when? And where? 96
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients 96
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 96
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients? 95
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 95
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study 94
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study 94
Timed-flat infusion (TFI) 5-fluorouracil with irinotecan and oxaliplatin in pancreatic adenocarcinomas: A single institution experience with FIr/FOx regimen 94
Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients 93
Validation of the pap score in advanced cancer patients who are candidates for palliative chemotherapy 93
Pain Characteristics and Analgesic Treatment in an Aged Adult Population: A 4-Week Retrospective Analysis of Advanced Cancer Patients Followed at Home. 92
Cancer care after natural disaster: Different countries, similar problems 92
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. 91
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy 91
Morphine in the treatment of incident pain triggered by vinorelbine infusion 90
Topical menthol for treatment of chemotherapy-induced peripheral neuropathy 90
Rapid resolution of refractory chemotherapy induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report 88
Orphan symptoms in advanced cancer patients followed at home 87
Palliative sedation in advanced cancer patients followed at home: A retrospective analysis 87
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 87
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey 86
Prognostic factors of survival in patients with advanced cancer admitted to home care 86
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 85
Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit 84
How do cancer patients receiving palliative care at home die? A descriptive study 83
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study 83
Palliative sedation in patients with advanced cancer followed at home: A prospective study 82
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 81
Pharmacokinetics in pelvic stop-flow infusion and hypoxic pelvic perfusion with and without hemofiltration. 81
Emergencies in patients with advanced cancer followed at home 80
Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting 80
Integration between oncology and palliative care: A plan for the next decade? 80
Supporto nutrizionale 78
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain 78
Re. “Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey” 78
Tumori Ginecologici 76
Palliative sedation at home: A medical act practicable everywhere 75
Clinical and psychometric validation of the BreSAS questionnaire for symptom assessment among breast cancer survivors 75
Is there a role for neurologist in an oncological home care team? 74
Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron 74
Opioid switching in patients with advanced cancer followed at home. A retrospective analysis 73
Topical morphine in the treatment of painful ulcers 72
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen 72
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a web based online survey among Italian experts on supportive care in cancer 67
Comment on ‘What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion’ 65
Totale 9.931
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.043
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 15 109 7 111 20 156 30
2021/2022469 18 24 46 21 27 6 11 41 36 6 40 193
2022/20232.108 133 151 32 237 192 200 2 137 898 14 61 51
2023/2024452 63 24 22 48 37 114 3 33 1 25 16 66
2024/20252.361 60 35 169 131 356 203 370 173 475 110 165 114
2025/20262.130 225 430 375 512 401 187 0 0 0 0 0 0
Totale 10.208